Advances and high demands in totally robotic surgery for rectal cancer
- 89 Downloads
Open low anterior resection for tumors located in the lower third of the rectum has three goals: precision of total mesorectal excision (TME), safe distal margins to prevent local recurrence after a sphincter-preserving procedure, and high ligation of the inferior mesenteric artery with splenic flexure mobilization. Can these surgical aims be achieved with a minimally invasive approach such as laparoscopic or robotic surgery? Park et al.  highlight this question in their report on robotic surgery for rectal cancer in the March issue of Surgical Endoscopy.
The standard of care for patients with resectable rectal cancer includes TME. This surgical strategy can improve both oncologic and quality-of-life (QOL) outcomes for patients with rectal cancer. Sphincter-preserving surgery, if feasible from an oncologic point of view, is crucial for the patient’s QOL. Therefore, low anterior resection (LAR) currently is thought to be the optimal surgical treatment if local recurrence can be...
KeywordsRectal Cancer Total Mesorectal Excision Inferior Mesenteric Artery Laparoscopic Total Mesorectal Excision Splenic Flexure Mobilization
Christos Katsios and Georgios Baltogiannis have no conflicts of interest or financial ties to disclose.
- 4.Katsios GC, Baltogiannis G; Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476Google Scholar
- 11.Glantzounis GK, Roukos DH, Baltogiannis G (2010) Comparative-effectiveness research to standardize retrieved nodes for quality control in colorectal cancer. Ann Surg 252(1):202–203; author reply 203Google Scholar
- 27.Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250Google Scholar
- 28.Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280; author reply e282–e283Google Scholar
- 29.Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Personalized Med 7(4):347–350Google Scholar